Presenting your poster at a Labroots Virtual Event can provide valuable research insights and feedback from peers in the comfort of your home or office. Every Labroots virtual event features a virtual ...

Proposals that are incomplete or received after the deadline will not be considered. All ESA Annual Meeting proposal and abstract deadlines are 5:00 PM Eastern so that technical support and ESA staff ...

Silver Spring, Md.—Scientists from around the world will present more than 500 abstracts in obesity science and medicine and related topics at the 39th Annual Meeting of The Obesity Society (TOS) at ...

REDWOOD CITY, Calif. & BOSTON--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, ...

SAN DIEGO, May 08, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services ...

Ibezapolstat is a novel, orally administered antibiotic being developed as a Gram-Positive Selective Spectrum (GPSS™) antibacterial. It is the first of a new class of DNA polymerase IIIC inhibitors ...

Bright Minds Biosciences will present scientific posters about various programs in development, including BMB-101, BMB-201 and BMB-202 Bright Minds Biosciences will participate in BIO Europe ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage cancer immunotherapy company developing novel biotherapeutics targeting immunosuppressive myeloid ...

ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics will feature 5 presentations highlighting the usefulness of AVISE ® testing at the American College of ...

University of Arkansas at Monticello second-year graduate students Cassandra Hug of Arvada, Colo., and Alyssa Mineau of Sunnyvale, Calif., were winners in the 2022 forestry research poster contest of ...

SUZHOU, China, Oct. 13, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, ...